MARKET

NTRA

NTRA

Natera Inc
NASDAQ
106.52
+1.01
+0.96%
Pre Market: 106.52 0 0.00% 08:45 07/24 EDT
OPEN
106.30
PREV CLOSE
105.51
HIGH
109.18
LOW
105.41
VOLUME
5.20K
TURNOVER
0
52 WEEK HIGH
117.23
52 WEEK LOW
36.90
MARKET CAP
13.08B
P/E (TTM)
-33.9798
1D
5D
1M
3M
1Y
5Y
1D
(NTRA) - Analyzing Natera's Short Interest
Natera's short percent of float has risen 15.19% since its last report. The company has 6.38 million shares sold short. Short interest is the number of shares that have been sold short but have not yet been covered. Short selling is when a trader sells shares of a company in the hope that the price will fall.
Benzinga · 23h ago
Voya Small Cap Growth Strategy Q2 2024 Commentary
The Voya Small Cap Growth Strategy outperformed the Russell 2000 Growth Index for the quarter ended June 30, 2024. The rally in U.S. Large cap growth was dominated by semiconductors, technology hardware and media and entertainment industries. Top individual contributors to performance included FTAI Aviation, Natera and Aspen Aerogels.
Seeking Alpha · 1d ago
Healthcare 2024 Second Half Outlook
Seeking Alpha · 2d ago
BRIEF-Natera To Redeem $287.5 Million Convertible Senior Notes Due 2027
Reuters · 2d ago
NATERA: TO REDEEM $287.5 MLN CONVERTIBLE SENIOR NOTES DUE 2027
Reuters · 2d ago
Weekly Report: what happened at NTRA last week (0715-0719)?
Weekly Report · 2d ago
Parnassus Growth Equity Fund Q2 2024 Investment Commentary
Seeking Alpha · 5d ago
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
Natera has outperformed the market over the past 5 years by 18.07% on an annualized basis. The company has an average annual return of 31.07%. If an investor bought $100 of NTRA stock 5 years ago, it would be worth $386.36 today.
Benzinga · 5d ago
More
About NTRA
Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.

Webull offers Natera Inc stock information, including NASDAQ: NTRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRA stock methods without spending real money on the virtual paper trading platform.